Formulation Development & Manufacturing: Match the Development Problem to the Scope of Work
Formulation Development & Manufacturing
This guide spans preformulation, dosage forms, delivery approaches, and clinical and commercial manufacturing. Define the molecule's development challenge and project stage before checking which experiments, scale-up, transfer, and manufacturing activities a provider can perform.
Questions to ask first
- Is the primary challenge solubility, stability, release, administration, or manufacturability, and which approach is being compared?
- Does the disclosed capability cover laboratory development, pilot work, clinical supply, or commercial production for the required dosage form?
- Is there traceable evidence for the scope of work, batch size, quality system, and transfer requirements, or do those details need confirmation?
Key terms
- Preformulation
- Studies of molecular and material properties that inform subsequent dosage-form and development decisions.
- ASD
- Amorphous solid dispersion, one of the solubility-enabling and formulation approaches tracked in this map.
- Development and manufacturing
- Formulation design and experimental work should be distinguished from scale-up, technology transfer, and batch production.
Evidence and scope
A public capability statement does not establish project fit or immediately available capacity. Equipment, platforms, and process case studies provide useful leads but do not predict performance for every molecule. Verify the specific facility, regulatory status, batch size, and scope of work separately.
Technology snapshot: 2026-11-01 · Research methods
